PE20010692A1 - Peptidos modificados y peptidomimeticos para el uso en inmunoterapia - Google Patents
Peptidos modificados y peptidomimeticos para el uso en inmunoterapiaInfo
- Publication number
- PE20010692A1 PE20010692A1 PE2000001107A PE0011072000A PE20010692A1 PE 20010692 A1 PE20010692 A1 PE 20010692A1 PE 2000001107 A PE2000001107 A PE 2000001107A PE 0011072000 A PE0011072000 A PE 0011072000A PE 20010692 A1 PE20010692 A1 PE 20010692A1
- Authority
- PE
- Peru
- Prior art keywords
- amino acids
- alkyl
- substitution
- ser
- amida
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Rehabilitation Therapy (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99203427 | 1999-10-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010692A1 true PE20010692A1 (es) | 2001-07-06 |
Family
ID=8240756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000001107A PE20010692A1 (es) | 1999-10-18 | 2000-10-17 | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1226167A1 (hu) |
JP (1) | JP2003512388A (hu) |
KR (1) | KR20020047245A (hu) |
CN (1) | CN1379786A (hu) |
AR (1) | AR026068A1 (hu) |
AU (1) | AU780238B2 (hu) |
BR (1) | BR0014803A (hu) |
CA (1) | CA2386398A1 (hu) |
CO (1) | CO5271650A1 (hu) |
CZ (1) | CZ20021356A3 (hu) |
HK (1) | HK1046693A1 (hu) |
HU (1) | HUP0203504A3 (hu) |
IL (1) | IL148778A0 (hu) |
MX (1) | MXPA02003520A (hu) |
NO (1) | NO20021763L (hu) |
NZ (1) | NZ518256A (hu) |
PE (1) | PE20010692A1 (hu) |
PL (1) | PL354590A1 (hu) |
RU (1) | RU2002113107A (hu) |
SK (1) | SK6842002A3 (hu) |
TR (1) | TR200201036T2 (hu) |
WO (1) | WO2001029081A1 (hu) |
ZA (1) | ZA200202577B (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002951212A0 (en) * | 2002-09-04 | 2002-09-19 | Monash University | A method of modulating cellular activity and molecules for use therein |
EP2016054A2 (en) * | 2006-04-06 | 2009-01-21 | Purdue Research Foundation | Derivatization-enhanced analysis of amino acids and peptides |
WO2008078190A2 (en) * | 2006-12-21 | 2008-07-03 | Universite De Geneve | Compounds for fluorescence imaging |
US8697384B2 (en) | 2008-01-23 | 2014-04-15 | Herlev Hospital | YKL-40 as a general marker for non-specific disease |
US8580520B2 (en) | 2008-09-15 | 2013-11-12 | Herlev Hospital | YKL-40 as a marker for gastrointestinal cancers |
EP3215172B1 (en) | 2014-11-07 | 2023-04-26 | Kineta Chronic Pain, Llc. | Modifications and uses of conotoxin peptides |
EP3466963A1 (en) * | 2017-10-05 | 2019-04-10 | Suigeneris Farmacosmetics, S.L. | Anticancer peptides and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL115744A (en) * | 1994-10-27 | 2000-07-16 | Akzo Nobel Nv | Peptides comprising a subsequence of human cartilage glycoprotein - 39 |
TW575583B (en) * | 1996-04-24 | 2004-02-11 | Akzo Nobel Nv | Novel peptides suitable for use in antigen specific immunosuppressive therapy |
DE69731747T2 (de) * | 1996-06-07 | 2006-02-02 | Astrazeneca Ab | Peptid derivate |
IL122233A (en) * | 1996-12-06 | 2001-04-30 | Akzo Nobel Nv | Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them |
-
2000
- 2000-10-12 MX MXPA02003520A patent/MXPA02003520A/es unknown
- 2000-10-12 EP EP00972790A patent/EP1226167A1/en not_active Withdrawn
- 2000-10-12 WO PCT/EP2000/010230 patent/WO2001029081A1/en not_active Application Discontinuation
- 2000-10-12 RU RU2002113107/15A patent/RU2002113107A/ru not_active Application Discontinuation
- 2000-10-12 HU HU0203504A patent/HUP0203504A3/hu unknown
- 2000-10-12 IL IL14877800A patent/IL148778A0/xx unknown
- 2000-10-12 CZ CZ20021356A patent/CZ20021356A3/cs unknown
- 2000-10-12 TR TR2002/01036T patent/TR200201036T2/xx unknown
- 2000-10-12 AU AU11396/01A patent/AU780238B2/en not_active Ceased
- 2000-10-12 PL PL00354590A patent/PL354590A1/xx not_active Application Discontinuation
- 2000-10-12 CN CN00814418A patent/CN1379786A/zh active Pending
- 2000-10-12 NZ NZ518256A patent/NZ518256A/en unknown
- 2000-10-12 KR KR1020027004940A patent/KR20020047245A/ko not_active Application Discontinuation
- 2000-10-12 BR BR0014803-2A patent/BR0014803A/pt not_active IP Right Cessation
- 2000-10-12 CA CA002386398A patent/CA2386398A1/en not_active Abandoned
- 2000-10-12 SK SK684-2002A patent/SK6842002A3/sk not_active Application Discontinuation
- 2000-10-12 JP JP2001531879A patent/JP2003512388A/ja not_active Withdrawn
- 2000-10-17 PE PE2000001107A patent/PE20010692A1/es not_active Application Discontinuation
- 2000-10-18 AR ARP000105458A patent/AR026068A1/es unknown
- 2000-10-18 CO CO00079334A patent/CO5271650A1/es not_active Application Discontinuation
-
2002
- 2002-04-02 ZA ZA200202577A patent/ZA200202577B/en unknown
- 2002-04-15 NO NO20021763A patent/NO20021763L/no not_active Application Discontinuation
- 2002-11-13 HK HK02108208.9A patent/HK1046693A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1046693A1 (zh) | 2003-01-24 |
AU1139601A (en) | 2001-04-30 |
IL148778A0 (en) | 2002-09-12 |
MXPA02003520A (es) | 2002-08-20 |
AR026068A1 (es) | 2002-12-26 |
EP1226167A1 (en) | 2002-07-31 |
JP2003512388A (ja) | 2003-04-02 |
HUP0203504A3 (en) | 2005-03-29 |
NO20021763D0 (no) | 2002-04-15 |
SK6842002A3 (en) | 2002-09-10 |
NZ518256A (en) | 2004-01-30 |
TR200201036T2 (tr) | 2002-08-21 |
PL354590A1 (en) | 2004-01-26 |
AU780238B2 (en) | 2005-03-10 |
RU2002113107A (ru) | 2004-01-10 |
NO20021763L (no) | 2002-04-15 |
CO5271650A1 (es) | 2003-04-30 |
CA2386398A1 (en) | 2001-04-26 |
WO2001029081A1 (en) | 2001-04-26 |
CN1379786A (zh) | 2002-11-13 |
BR0014803A (pt) | 2002-06-11 |
HUP0203504A2 (hu) | 2003-04-28 |
CZ20021356A3 (cs) | 2002-07-17 |
KR20020047245A (ko) | 2002-06-21 |
ZA200202577B (en) | 2003-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20120914A1 (es) | Compuestos glucagon activo de receptor de gip | |
BR0114630A (pt) | Secretagogos de hormÈnio do crescimento | |
PE20090108A1 (es) | Coagonistas del receptor de glucagon/glp-1 | |
ES2194224T3 (es) | Uso de analogos y derivados de glp-1 administrados perifericamente para la regulacion de la obesidad. | |
AR036196A1 (es) | Agentes de contraste multimericos dirigidos a base de peptidos | |
CY1113850T1 (el) | Νεα παραγωγα ινσουλινης | |
BRPI0517493A (pt) | polinucleotìdeo isolado, promotor vetor de expressão, célula hospedeira e uso de um polinucleotìdeo | |
PE20010692A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia | |
MX2009012675A (es) | Tensioactivos reconstituidos que tienen propiedades mejoradas. | |
ES8105698A1 (es) | Procedimiento para la obtencion de octapeptidos ciclicos | |
ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
ES2689746T3 (es) | Anticuerpos monoclonales contra la claudina-18 para el tratamiento de cáncer | |
PA8527201A1 (es) | Peptidos ciclados con actividad agonista para el receptor de la melanocortina-4 (mc4-r) | |
HN1998000157A (es) | Agonistas de prostaglandinas | |
PE20081250A1 (es) | FUSIONES Fc CON RECEPTOR PARA FGF SOLUBLE MODIFICADAS, CON ACTIVIDAD BIOLOGICA MEJORADA | |
BRPI0515118A (pt) | conjugados de hormÈnio do crescimento humano com polietileno glicol | |
EP2189471A4 (en) | PEPTIDE FOXM1 AND MEDICINAL AGENT COMPRISING SAME | |
PE20211466A1 (es) | Analogos de proteina tirosina-tirosina y metodos de uso de esta | |
ATE384743T1 (de) | Aminoterminal modifizierte parathyroidhormon (pth) analoge | |
MX2009010965A (es) | Péptidos de tem8 y vacunas que los contienen. | |
AR008094A1 (es) | Proceso para la sintesis de un polipeptido sintetico analogo a la hormona paratiroidea o al peptido relacionado con la hormona paratiroidea y procesopara la preparacion de una composicion farmaceutica. | |
AR043688A1 (es) | Analogos del peptido yy | |
MX2020009150A (es) | Anfifilos de cpg y usos de los mismos. | |
MX2022004598A (es) | Compuestos inmunogenicos para el tratamiento del cancer suprarrenal. | |
PE20040705A1 (es) | Polipeptido t20 pegilado |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |